Cargando…
Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy
BACKGROUND: The role of neutrophil–lymphocyte ratio (NLR) as a predictor for survival in single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains unclear. We performed an observational cohort study to determine the role of pretreatment NLR in predicting survival of early-stag...
Autores principales: | Huang, Karen, Prasad, Sharan, Ma, Sung Jun, Yu, Han, Iovoli, Austin J., Farrugia, Mark K., Dexter, Elizabeth U., Demmy, Todd L., Malik, Nadia K., Singh, Anurag K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024425/ https://www.ncbi.nlm.nih.gov/pubmed/36932396 http://dx.doi.org/10.1186/s12885-023-10719-3 |
Ejemplares similares
-
Comparison of Survival Outcomes of Single- and Five-Fraction Schedules of Stereotactic Body Radiation Therapy for Early-Stage Central or Peripheral NSCLC
por: Huang, Karen, et al.
Publicado: (2023) -
Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic Review
por: Iovoli, Austin J., et al.
Publicado: (2022) -
Right Atrial Dose Is Associated with Worse Outcome in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Tumors
por: Farrugia, Mark, et al.
Publicado: (2022) -
Exceeding Radiation Dose to Volume Parameters for the Proximal Airways with Stereotactic Body Radiation Therapy Is More Likely for Ultracentral Lung Tumors and Associated with Worse Outcome
por: Farrugia, Mark, et al.
Publicado: (2021) -
Evaluation of Preoperative Chemotherapy or Radiation and Overall Survival in Patients With Nonmetastatic, Resectable Retroperitoneal Sarcoma
por: Ma, Sung Jun, et al.
Publicado: (2020)